Ascentage Pharma Group International (AAPG)
NASDAQ: AAPG · Real-Time Price · USD
24.40
-0.65 (-2.59%)
At close: Feb 26, 2026, 4:00 PM EST
24.10
-0.30 (-1.23%)
After-hours: Feb 26, 2026, 4:10 PM EST
AAPG Market Cap
AAPG has a market cap or net worth of $2.24 billion as of February 26, 2026. Its market cap has increased by 40.34% in one year.
Market Cap
2.24B
Enterprise Value
2.25B
1-Year Change
40.34%
Ranking
Category
Stock Price
$24.40
Market Cap Chart
Since the IPO on June 13, 2022, AAPG's market cap has increased from $554.36M to $2.24B, an increase of 303.80%. That is a compound annual growth rate of 45.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 26, 2026 | 2.24B | -9.40% |
| Dec 31, 2025 | 2.47B | 36.38% |
| Dec 31, 2024 | 1.81B | 82.20% |
| Dec 29, 2023 | 994.30M | 16.90% |
| Dec 30, 2022 | 850.58M | 53.44% |
| Jun 13, 2022 | 554.36M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Arcus Biosciences | 2.51B |
| Disc Medicine | 2.50B |
| Adaptive Biotechnologies | 2.46B |
| Immunome | 2.45B |
| Mineralys Therapeutics | 2.34B |
| Dianthus Therapeutics | 2.31B |
| Galapagos NV | 2.21B |
| Ultragenyx Pharmaceutical | 2.18B |